To further investigate the molecular mechanism by which LMW-PTP increases chemoresistance in CML, we analyzed the levels of phospho-Src and phospho-ABL after knocking down LMW-PTP in K562 and Lucena-1 cells. This evidence concerns the gene ACP1 and chronic myelogenous leukemia, BCR-ABL1 positive.